| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |